Rudi Mariën

Rudi Mariën is a Belgian scientist and businessman. He is Chairman of the Belgian biotech company Innogenetics.

Education

Rudi Mariën obtained a degree in pharmaceutical sciences from the University of Ghent, specializing in clinical biology.

Career

On 18 July 1985, he co-founded the Belgian biotech company Innogenetics, together with Erik Tambuyzer and Hugo Van Heuverswyn and has been its Chairman since then. Besides Innogenetics, he founded several clinical laboratories. He is at present managing director of BARC NV, an international centralized clinical laboratory. He is also CEO of Gengest BVBA (management company), Biovest CVA, LMA BVBA, Laboraco BVBA, and he is director of DSJ Bruxelles NV and Oystershell NV. Rudi Mariën is a member of the American Association for Clinical Chemistry.

Sources


gollark: Especially since you can run terminals pretty well over low-bandwidth networking.
gollark: I think mouse/visual IO is better for quite a few things, but terminals are very good for some tasks.
gollark: Why have icons? Apple devices have high-res screens, right? Just make it say the name of the application in very small text over and over again to fill up the squares.
gollark: Personally I consider rounding and shading very uncool.
gollark: Yes, why?
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.